SAN FRANCISCO, June 16, 2023 Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced the details of its poster presentation at the European Association for the Study of the Liver (EASL) Congress 2023, being held from June 21-24 in Vienna, Austria. EASL is a leading professional society and
Better Therapeutics, Inc : Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Institute for Liver Health II, which does business as Arizona Clinical Trials and Arizona Liver Health (collectively, "ALH"), is notifying.